Lopez, Anthony
Harada, Kazuto
Vasilakopoulou, Maria
Shanbhag, Namita
Ajani, Jaffer A.
Article History
First Online: 7 January 2019
Compliance with Ethical Standards
:
: No external funding was used in the preparation of this manuscript.
: Anthony Lopez has received research funding from Roche, has served as consultant for Amgen, received lecture fees from Vifor Pharma, and received travel accommodation expenses (not for this work) from Abbvie, Amgen, MSD, Vifor-Pharma. Jaffer A. Ajani has received honoraria from Lilly, Bayer, Novartis, Five Prime Therapeutics, Taiho Pharmaceutical, Genentech, and Roche, received research funding from Novartis, Bristol-Myers Squibb, Taiho Pharmaceutical, Roche/Genentech, MedImmune, Amgen, Lilly/ImClone, Merck, Delta-Fly Pharma, Gilead Sciences, and Takeda, and received travel accommodation expenses (not for this work) from Novartis, Bayer, and Five Prime Therapeutics. Kazuto Harada, Maria Vasilakopoulou, and Namita Shanbhag declare that they have no conflicts of interest that might be relevant to the contents of this manuscript.